Actavis Completes Forest Laboratories Acquisition LEARN MORE>
Actavis Completes Forest Laboratories Acquisition
>Go!

Product Prescribing

Allergan Product Prescribing and Labeling Information

Product name Patient Information
ACAMPROSATE CALCIUM Delayed-Release Tablets PDF
Actigall ®(ursodiol, USP) capsules PDF
ACTONEL® (risedronate sodium) tablets PDF
ACULAR LS® (ketorolac tromethamine ophthalmic solution) 0.4% PDF
ACULAR® (ketorolac tromethamine ophthalmic solution) 0.5% PDF
ACUVAIL® (ketorolac tromethamine ophthalmic solution) 0.45% PDF
ACZONE® (dapsone) Gel 5% PDF
ACZONE® (dapsone) Gel, 7.5% PDF
AeroChamber Plus® Flow-Vu® Anti-Static Valved Holding Chamber PDF
AeroChamber Plus® Flow-Vu® aVHC Small Mask/Medium Mask PDF
ALOCRIL® (nedocromil sodium ophthalmic solution) 2% PDF
Alora (Estradiol Transdermal System, USP) PDF
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% PDF
AMETHIA Lo tablets for oral use PDF
Amethia™ Levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets for oral use PDF
ANDRODERM® (testosterone transdermal system), for topical use CIII PDF
AquADEKs® Chewable Tablets (aqua-dex’) Multivitamin and Mineral Supplement PDF
Armour® Thyroid (thyroid tablets, USP) PDF
ASACOL (mesalamine) delayed-release tablets, for oral use PDF
ASACOL® HD (mesalamine) delayed-release tablets, for oral use PDF
ATELVIA® (risedronate sodium) delayed-release tablets PDF
AVAGE® (tazarotene) Cream 0.1% PDF
AVYCAZ (ceftazidime and avibactam) for injection, for intravenous use PDF
AZELEX® (azelaic acid cream) 20% PDF
BENTYL (dicyclomine hydrochloride) capsules, for oral use, BENTYL (dicyclomine hydrochloride) tablets, for oral use, BENTYL (dicyclomine hydrochloride) injection, for intramuscular use PDF
BETAGAN® (levobunolol hydrochloride ophthalmic solution, USP) 0.5% PDF
BLEPH®-10 (sulfacetamide sodium ophthalmic solution, USP) 10% PDF
BLEPHAMIDE® (sulfacetamide sodium − prednisolone acetate ophthalmic suspension, USP) 10%/0.2% PDF
BLEPHAMIDE® (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% PDF
BOTOX® (onabotulinumtoxinA) PDF
BOTOX® (onabotulinumtoxinA) Injection Needle PDF
BOTOX® and BOTOX® Cosmetic Med Guide PDF
BOTOX® Cosmetic (onabotulinumtoxinA) PDF
Brevicon® (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg) PDF
BYSTOLIC® (nebivolol) tablets, for oral use PDF
BYVALSON (nebivolol and valsartan) tablets, for oral use PDF
Byvalson (nebivolol/valsartan) tablets - Patient information PDF
CAMPRAL® (acamprosate calcium) Delayed-Release Tablets PDF
CANASA® (mesalamine) rectal suppository PDF
CARAFATE® (sucralfate) Suspension PDF
Celexa® (citalopram hydrobromide) Tablets PDF
CERVIDIL (dinoprostone, 10 mg) PDF
COMBIGAN® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% PDF
Cordran® Tape Flurandrenolide Tape, USP PDF
Crinone® (progesterone gel) PDF
DALVANCE (dalbavancin) for injection, for intravenous use PDF
DELZICOL (mesalamine) delayed-release capsules, for oral use PDF
Diltiazem hydrochloride, extended-release capsules, USP PDF
DORYX® (doxycycline hyclate delayed-release tablets) PDF
ELESTAT® (epinastine HCl ophthalmic solution) 0.05% PDF
ENABLEX ® (darifenacin) extended-release tablets PDF
ESTRACE® (estradiol vaginal cream, USP, 0.01%) PDF
ESTROSTEP® Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets*) PDF
Femcon Fe PDF
Femcon Fe PDF
femhrt® (norethindrone acetate/ethinyl estradiol tablets) PDF
Femring® (estradiol acetate vaginal ring) PDF
FETZIMA® (levomilnacipran) extended-release capsules, for oral use PDF
Fioricet (butalbital, acetaminophen, and caffeine capsules, USP) PDF
Fioricet with Codeine CIII (butalbital, acetaminophen, caffeine, and codeine phosphate) Capsules PDF
Fiorinal® with Codeine C-III (Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP) PDF
FLUOROPLEX® (fluorouracil) 1% Topical Cream PDF
FLUTTER® Mucus Clearance Device PDF
FML FORTE® (fluorometholone ophthalmic suspension) 0.25% PDF
FML® (fluorometholone ophthalmic ointment) 0.1% PDF
FML® (fluorometholone ophthalmic suspension, USP) 0.1% PDF
GELNIQUE 3% (oxybutynin) gel 3%, for topical use PDF
GENERESS Fe (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets) PDF
INFeD (Iron Dextran Injection USP) PDF
JUVÉDERM VOLUMA® XC PDF
JUVÉDERM® Ultra PDF
JUVÉDERM® Ultra Plus PDF
JUVÉDERM® Ultra Plus XC PDF
JUVÉDERM® Ultra XC PDF
KADIAN® (morphine sulfate) extended-release capsules, for oral use, CII PDF
KYBELLA (deoxycholic acid) injection, for subcutaneous use PDF
LASTACAFT® (alcaftadine ophthalmic solution) 0.25% PDF
LATISSE® (bimatoprost ophthalmic solution) 0.03% PDF
LEVOTHROID® (levothyroxine sodium tablets, USP) PDF
Lexapro® (escitalopram oxalate) Tablets, Lexapro® (escitalopram oxalate) Oral Solution PDF
LILETTA (levonorgestrel-releasing intrauterine system) PDF
LINZESS (linaclotide) capsules, for oral use PDF
Lo Loestrin® Fe PDF
Lo Loestrin® Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) PDF
LUMIGAN® 0.01% (bimatoprost ophthalmic solution) PDF
Minastrin®24 Fe PDF
MONUROL (fosfomycin tromethamine) sachet PDF
NAMENDA (memantine HCl) tablets, for oral use, NAMENDA (memantine HCl) solution, for oral use PDF
NAMENDA XR (memantine hydrochloride) extended release capsules, for oral use PDF
NAMZARIC (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use PDF
NUVESSA TM (metronidazole vaginal gel 1.3%) PDF
OCUFEN® (flurbiprofen sodium ophthalmic solution, USP) 0.03% PDF
OCUFLOX® (ofloxacin ophthalmic solution) 0.3% PDF
OZURDEX® (dexamethasone intravitreal implant) 0.7 mg PDF
POLYTRIM® (polymyxin B sulfate and trimethoprim ophthalmic solution, USP) PDF
PRED FORTE® (prednisolone acetate ophthalmic suspension, USP) 1% PDF
PRED MILD® (prednisolone acetate ophthalmic suspension, USP) 0.12% PDF
PRED-G® (gentamicin and prednisolone acetate ophthalmic ointment, USP) 0.3%/0.6% PDF
PRED-G® (gentamicin and prednisolone acetate ophthalmic suspension, USP) 0.3%/1% PDF
PreQue 10® PDF
PREVAGE® MD PDF
PYLERA® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) capsules PDF
RAPAFLO® (silodosin) capsules PDF
RECTIV (nitroglycerin) Ointment 0.4%, for intra-anal use PDF
REFRESH CONTACTS® Contact Lens Comfort Drops PDF
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% PDF
SANCTURA XR® (trospium chloride extended release capsules) PDF
SANCTURA® (trospium chloride) PDF
SAPHRIS® (asenapine) sublingual tablets PDF
Savella® (milnacipran HCl) Tablets PDF
Speculite® (Vaginal illumination for Papsure®) PDF
TAZORAC® (tazarotene) Cream 0.05% and 0.1% PDF
TAZORAC® (tazarotene) Gel 0.05% and 0.1% PDF
TEFLARO® (ceftaroline fosamil) for injection, for intravenous use PDF
Thyrolar Tablets (Liotrix Tablets, USP) PDF
Tiazac® (diltiazem hydrochloride) PDF
TRELSTAR® (triptorelin pamoate for injectible suspension) PDF
TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) PDF
ULTRESA (pancrelipase) delayed-release capsules, for oral use PDF
URSO 250® (ursodiol) tablets, for oral use,URSO Forte® (ursodiol) tablets, for oral use PDF
VANIQA® (eflornithine hydrochloride) Cream, 13.9% PDF
VIBERZI (eluxadoline) tablets, for oral use, CIV PDF
VIIBRYD (vilazodone hydrochloride) tablets, for oral use PDF
VIOKACE (pancrelipase) tablets, for oral use PDF
VRAYLAR (cariprazine) capsules, for oral use PDF
ZENPEP® (pancrelipase) delayed release capsules PDF
ZYMAXID® (gatifloxacin ophthalmic solution) 0.5% PDF
U.S. Products
Find the current product labeling information for other company products in our Product Database.
Labeling and Safety Information
Allergan Natrelle® Collection and Breast Aesthetics Product Labeling and Safety Information